system particularly with regard to timeliness of stent removal and incidence of retained or missed stents. CONCLUSIONS: Our integrated stent tracking system embedded within EPIC is a feasible mechanism for potentially reducing the incidence of retained stents while adding minimal administrative and financial burden on the surgeon and hospital. Current studies are ongoing to assess the efficacy of our system at preventing retained stents.
INTRODUCTION AND OBJECTIVES: JJ stenting represents one of the most significant causes for patient discomfort and dissatisfaction following ureteroscopy. At the author's institution, which is a large tertiary referral centre for complex stones, standard stent removal was undertaken with a flexible cystoscope (FC) in the Endoscopy Department by a doctor, and was prone to delays through meeting requirements for cancer investigations. The 'Isiris AE' (Coloplast) is a single use stent removal system consisting of a 'camera on chip' disposable FC with integrated grasper. We examine the feasibility and impact on waiting times of a nurse led stent removal service using this system, which can be used in any clinical space.
METHODS: A specialist stone nurse undertook training in FC approved by The British Association of Urological Surgeons (BAUS). Once competency was reached a nurse led service was offered to patients in the outpatient setting. The training time to competency was recorded.
A prospective database from April to October 2018 reveals the nurse led service completed 94 stent removals. In comparison data between July and December 2016 showed 54 stent removals completed by a doctor in the endoscopy department. The delays in stent removal compared to the "ideal" stent removal date (plus or minus 3 days tolerance allowed) were compared between the two pathways.
RESULTS: The specialist nurse undertook BAUS theory training before going on to observe 14 FCs (recommended 10) followed by completion of 78 (recommended 40) FCs under supervision. A further 15 stent removals were completed using the Isiris cystoscope under supervision. Competency was reached after this time using an approved BAUS/BAUN competency package.
94 stent removals were booked in the nurse group, of which 87 were undertaken. In three of these the nurse was unable to remove the stent. In one case due to poor views in the bladder with debris, in one case because of encrustation, and in the remaining case due to inability to navigate through a tortuous prostatic urethra.
74 of 87 patients in the nurse removal ISIRIS group had their stent removed on time, whereas only 16 of 54 patients had their stents removed on time in the doctor stent removal group (p<0.0001, Fischer's exact test).
Only 3 of 13 patients who had a delayed stent removal in the nurse led group had a delay of more than 21 days, but in the doctor led group this number was 12 out of 38.
CONCLUSIONS: This study has shown that it is possible to introduce a nurse led stent removal service. Introduction of this service using the ISIRIS system has led to a reduction in delays of stent removal, which are likely to translate into significant quality of life improvements for patients. Further work is being undertaken to investigate comparisons of emergency department attendance and/or admission rates to identify if timely stent removals can reduce post-operative hospital episodes.
Source of Funding: none

MP23-20 PEDIATRIC UROLITHIASIS: OVERVIEW OF TREATMENT OPTIONS AND OUTCOMES FROM A SINGLE CENTER
Salvatore Micali*, Luigi bevilacqua, Modena, Italy; Ahmed Elsherbiny, Tanta, Egypt; Corradino Di Pietro, Silvia Ciarlariello, Viviana Durante, Modena, Italy; Ahmed Eissa, Tanta, Egypt; Stefano Puliatti, Nancy Ferrari, Alessandro Mofferdin, Maria Chiara Sighinolfi, Giampaolo Bianchi, Bernardo Maria Rocco, Modena, Italy INTRODUCTION AND OBJECTIVES: There is a growing interest in pediatric urolithiasis because of the increasing incidence over the last two decads especially in western population and developing countries. Pediatric urolithiasis can cause significant renal morbidity, or even renal failure.
On contrary to adults, the symptomatology in children could be indefinite and vague. There is an abundance of literature on adult urolithiasis, but series from the pediatric population are still poor. We herein review our experience for the treatment of urolithiasis in pediatric patients.
METHODS: We retrospectively collected data from the medical records of all children treated for urolithiasis at our centre starting from January 2005 to June 2018. We reviewed and statistically analysed demographic and preoperative patients' characteristics (sex, age, comorbidities, preoperative renal function), stone (stone size, location, and Hounsfield units), intraoperative (operative time, complications, and hemoglobin drop) and follow-up data (stone-free rate [SFR] ). SFR was defined as the absence of any stone fragment more than or equal to 2 mm. Any patient with missing data was excluded from the analysis. The treatment modalities performed were extracorporeal shock wave lithotripsy (ESWL), ureteroscopy and percutaneous nephrolithotomy (PCNL) RESULTS: From January 2005 to June 2018 we treated 73 children (31 PCNL,21 ureteroscopy, and 21 ESWL). The mean age was 10.2 and male:female ratio was 3:1. Mean stone size was 11 mm (5-20 mm), 23 mm (15-35 mm), and 9 mm (5-12 mm) for ureteroscopy, PCNL, and ESWL, respectively.
Mean operative time was 192 minutes and 89.5 minutes for PCNL and ureteroscopy, respectively. Ureteroscopies were performed using Stortz XFlexC Ureteroscope (8 FR); the initial pediatric series of PCNL was carried out with 26 Fr Nephroscope, and then changed to Minimally Invasive PCNL instruments (MIP) 9.5 and 15 Fr.
Global SFR after the primary procedure was 88%; the remaining cases underwent a second-look endourological approach. Clavien Dindo II complications (fever in all cases, responsive to antibiotic treatment) were observed in 10/73 patients.
CONCLUSIONS: The introduction and availability of smaller instruments have led to safer use of percutaneous endoscopy and ureteroscopy in children, with results and complications comparable to those in adults. The availabilty of ESWL may improve the outcomes of pediatric stone treatment.
As a consequence, the availability of adequate minimally invasive instruments is of paramount importance to safely manage these delicate patients.
